Original article from: Newsweek posted on May 19, 2015. by Amy Maxmen Under...
Researchers Cite Experts’ Findings of NEIDL Safety
Original article from: BU Today, posted on April 17, 2014. By Art Jahnke
In a discussion whose outcome may determine if Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) will conduct research involving pathogens such as the Ebola and Marburg viruses, speakers for and against research at BioSafety Level 4 (BSL-4) faced off last night at a lengthy Boston City Council hearing on a proposed ordinance to ban that level of research in the city. The ordinance was put forth by Councilman Charles Yancey, who told the standing-room-only crowd that he feared that BSL-4 research could pose a serious risk to the health and safety of the community.
While Yancey and several opponents of BSL-4 research tried to persuade the city council to support the ban, proponents, including Barbara Ferrer (SPH’88), director of the Boston Public Health Commission (BPHC), and M. Anita Barry, director of the BPHC Infectious Diseases Bureau, argued that reliable safety precautions have been put in place. Representatives of the biotech industry also spoke in favor of BSL-4 research, maintaining that banning BSL-4 research would inhibit the growth of life sciences research in Boston.